2867-62-1

Basic information

• Product Name: Benzenebutanoic acid, a-methyl-b-oxo-, ethyl ester
• CAS NO: 2867-62-1
• Molecular Formula: C13H16O3
• Molecular Weight: 220.268
• Mol File: 2867-62-1.mol
• Article Data: 17

Chemical Properties

• CAS DataBase Reference: Benzenebutanoic acid, a-methyl-b-oxo-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenebutanoic acid, a-methyl-b-oxo-, ethyl ester(2867-62-1)
• EPA Substance Registry System: Benzenebutanoic acid, a-methyl-b-oxo-, ethyl ester(2867-62-1)

Safety Data

• Hazardous Substances Data: 2867-62-1(Hazardous Substances Data)

Upstream product

• 29392-77-6 sodium 3-ethoxy-3-oxo-1-phenylprop-1-en-1-olate 
• 74-88-4 methyl iodide 
• 623-73-4 diazoacetic acid ethyl ester 
• 103-79-7 1-phenyl-acetone 
• 718-08-1 ethyl 3-oxo-4-phenylbutyrate 
• 103-80-0 phenylacetyl chloride 
• 103-82-2 phenylacetic acid 
• 103362-70-5 potassium ethyl methylmalonate 
• 412019-21-7 ethyl 2-acetyl-3-oxo-4-phenylbutanoate 
• 55628-82-5 1-(Phenylacetyl)imidazole 
• 140-29-4 phenylacetonitrile 
• 535-11-5 Ethyl 2-bromopropionate 
• 85515-80-6 1-(ethoxycarbonyldiazomethyl)-2-phenylisopropyl alcohol 
• 21382-82-1 (carbethoxyethylidene)triphenylphosphorane 

Downstream Products

• 93737-91-8 β-Methyl-β-aethoxycarbonyl-γ-oxo-δ-phenyl-valeriansaeure-aethylester 
• 169772-16-1 6-benzyl-4-hydroxy-2-mercapto-5-methylpyrimidine 
• 1444000-54-7 6-benzyl-1-ethoxymethyl-5-methyluracil 
• 1444000-57-0 6-benzyl-1-benzyloxymethyl-5-methyluracil 
• 951764-34-4 6-benzyl-5-methyl-2-[(phenylcarbonylmethyl)thio]pyrimidin-4(3H)-one 
• 1007-32-5 benzyl ethyl ketone 
• 1410791-81-9 ethyl 2-(((benzyloxy)carbonyl)(hydroxy)amino)-2-methyl-3-oxo-4-phenylbutanoate 
• 192440-07-6 2-Acetylamino-2-(5-benzyl-3-ethoxy-isoxazol-4-ylmethyl)-malonic acid diethyl ester 
• 192440-04-3 5-Benzyl-4-bromomethyl-3-ethoxy-isoxazole 
• 192440-02-1 5-benzyl-3-ethoxy-4-methylisoxazol 
• 192440-01-0 5-Benzyl-4-methyl-isoxazol-3-ol 

Relevant articles and documents

KRAS G12C INHIBITORS

The present invention relates to compounds that, inhibit KRas G12C, In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

KRAS G12C INHIBITORS

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Synthesis and biological evaluation of novel anti-hepatitis C virus (HCV) agents: 2-hydroxylphenethyl sulfanyl-oxopyrimidines

A novel series of dihydro-hydroxyl-phene-thylsulfanyl-ω-cyclohexyl/phenyl-oxopyrimidine derivatives have been synthesized and their in vitro anti-hepatitis C virus activities have been evaluated using Huh 7.5.1 cells. Some of the compounds showed moderate